Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

PURPOSE: Antipsychotic monotherapy is often recommended over antipsychotic polypharmacy because of fewer adverse events, reduced treatment complexity, and lower medication cost. This study compared the rate and the duration of antipsychotic monotherapy following initiation of olanzapine or risperido...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Wenyu, Ascher-Svanum, Haya, Tanji, Yuka, Flynn, Jennifer A, Takahashi, Michihiro, Conley, Robert R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385585/
https://www.ncbi.nlm.nih.gov/pubmed/22745559
http://dx.doi.org/10.2147/NDT.S25662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385585/
https://www.ncbi.nlm.nih.gov/pubmed/22745559
http://dx.doi.org/10.2147/NDT.S25662

Ejemplares similares